Variables | N | % of N | |
Age | Mean (SD) | 55.2 (10.4) | |
Median (IQR) | 56 (49 - 62) | ||
Min, Max | (31; 73) | ||
Histological type (recoded) | Papillary serous adenocarcinoma | 23 | 63.9 |
Adenocarcinoma of unknown primary | 6 | 16.7 | |
Poorly differentiated carcinoma | 5 | 13.9 | |
Peritoneal papillary serous carcinoma | 2 | 5.6 | |
Clinical stage classification (recoded) | IIIC | 28 | 77.8% |
IVA | 1 | 2.8% | |
IVB | 7 | 19.4% | |
Karnofsky index | 100 | 8 | 22.2% |
90 | 25 | 69.4% | |
80 | 3 | 8.3% | |
Metastatic site | None | 28 | 77.8% |
Mediastinal lymphadenopathy | 2 | 5.6% | |
Liver | 4 | 11.1% | |
Pleura | 1 | 2.8% | |
Lung | 1 | 2.8% | |
Ascites | Yes | 36 | 100% |
Oligometastatic disease | Yes | 3 | 8% |
No | 33 | 92% | |
Concurrent disease | Yes | 28 | 77.8% |
No | 8 | 22.2% | |
Hypertension | Yes | 15 | 41.7% |
No | 21 | 58.3% | |
Diabetes Mellitus | Yes | 6 | 16.7% |
No | 30 | 83.3% |